Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | Pushing the boundaries in prostate cancer imaging

Ian Davis • 3 Jun 2019
ASCO 2019
Genitourinary Cancer Prostate Cancer

Ian Davis, MB BS, PhD, FRACP, FAChPM, of the Monash University Eastern Health Clinical School, Melbourne, Australia, discusses how the use of both radio imaging and therapy for prostate cancer are progressing at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

More from Ian Davis

5:16
ENZAMET: Enzalutamide for metastatic prostate cancer
Ian Davis • 3 Jun 2019
1:02
Ian Davis envisages the evolution of prostate cancer care
Ian Davis • 3 Jun 2019
3:13
Prostate cancer: treatment sequencing and choice
Ian Davis • 3 Jun 2019
1:55
ARCHES trial overview: ADT plus enzalutamide for metastatic hormone-sensitive prostate cancer
Ian Davis • 6 Mar 2019

Related Videos

4:05
Evaluating triplet therapy in metastatic hormone sensitive prostate cancer
Nick James • 24 Apr 2024
10:42
Management of prostate cancer from the patient perspective
David Matheson • 11 Apr 2024
2:26
Prognostic factors of renal cell cancer in elderly patients
Teemu Murtola • 9 Apr 2024
2:44
The effect of hypoxia on lipid metabolism and prostate cancer tumor growth
Teemu Murtola • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals